Skip to main content
Top
Published in: BMC Geriatrics 1/2024

Open Access 01-12-2024 | Research

A review of the enhanced CJD surveillance feasibility study in the elderly in Scotland, UK

Authors: Lovney Kanguru, Sarah Cudmore, Gemma Logan, Briony Waddell, Colin Smith, Anna Molesworth, Richard Knight

Published in: BMC Geriatrics | Issue 1/2024

Login to get access

Abstract

Background

Variant Creutzfeldt - Jakob disease (vCJD) arose from dietary contamination with bovine-spongiform-encephalopathy (BSE). Because of concerns that vCJD-cases might be missed in the elderly, a feasibility study of enhanced CJD surveillance on the elderly was begun in 2016. Recruitment was lower than predicted. We describe a review of the challenges encountered in that study: identification, referral, and recruitment, and the effects of actions based on the results of that review.

Methods

Review was conducted in 2017. Study data for all eligible cases identified and referred from one participating service (Anne Rowling clinic (ARC)) was curated and anonymised in a bespoke database. A questionnaire was sent out to all the clinicians in medicine of the elderly, psychiatry of old age and neurology (including ARC) specialties in NHS Lothian, exploring possible reasons for low recruitment.

Results

Sixty-eight cases were referred from the ARC (March 2016-September 2017): 25% were recruited. Most cases had been referred because of diagnostic uncertainty. No difference was seen between those recruited and the non-recruited, apart from age and referrer. Twelve of 60 participating clinicians completed the questionnaire: only 4 had identified eligible cases. High workload, time constraints, forgetting to refer, unfamiliarity with the eligibility criteria, and the rarity of eligible cases, were some of the reasons given. Suggestions as to how to improve referral of eligible cases included: regular email reminders, feedback to referrers, improving awareness of the study, visible presence of the study team, and integration of the study with other research oriented services. These results were used to increase recruitment but without success.

Conclusion

Recruitment was lower than predicted. Actions taken following a review at 21 months did not lead to significant improvement; recruitment remained low, with many families/patients declining to take part (75%). In assessing the failure to improve recruitment, two factors need to be considered. Firstly, the initial referral rate was expected to be higher because of existing patients already known to the clinical services, with later referrals being only newly presenting patients. Secondly, the unplanned absence of a dedicated study nurse. Searching digital records/anonymised derivatives to identify eligible patients could be explored.
Literature
1.
go back to reference Urwin PJ, Thanigaikumar K, Ironside JW, Molesworth A, Knight RS, Hewitt PE, Llewelyn C, Mackenzie J, Will RG. Sporadic creutzfeldt–jakob Disease in 2 plasma product recipients, United Kingdom. Synopsis 2017 23:6. Urwin PJ, Thanigaikumar K, Ironside JW, Molesworth A, Knight RS, Hewitt PE, Llewelyn C, Mackenzie J, Will RG. Sporadic creutzfeldt–jakob Disease in 2 plasma product recipients, United Kingdom. Synopsis 2017 23:6.
2.
go back to reference Urwin PJ, Mackenzie JM, Llewelyn CA, Will RG. Creutzfeldt–Jakob Disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review study. Vox Sang. 2006;110:310–6.CrossRef Urwin PJ, Mackenzie JM, Llewelyn CA, Will RG. Creutzfeldt–Jakob Disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review study. Vox Sang. 2006;110:310–6.CrossRef
4.
go back to reference National CJD. Research & Surveillance Unit. Latest NCJDRSU CJD monthly statistics. Available at: Data and Reports | CJD (ed.ac.uk). National CJD. Research & Surveillance Unit. Latest NCJDRSU CJD monthly statistics. Available at: Data and Reports | CJD (ed.ac.uk).
5.
go back to reference Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, Tuzi NL, Head MW, Ironside JW, Will RG, Manson JC. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5(5):393–8.CrossRefPubMed Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, Tuzi NL, Head MW, Ironside JW, Will RG, Manson JC. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5(5):393–8.CrossRefPubMed
7.
go back to reference Clewley JP, Kelly CM, Andrews N, et al. Prevalence of Disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338. Clewley JP, Kelly CM, Andrews N, et al. Prevalence of Disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338.
8.
go back to reference Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675.CrossRefPubMedPubMedCentral Gill ON, Spencer Y, Richard-Loendt A, et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ. 2013;347:f5675.CrossRefPubMedPubMedCentral
9.
go back to reference Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol. 2004;203(3):733–39.CrossRefPubMed Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol. 2004;203(3):733–39.CrossRefPubMed
10.
go back to reference Turnbull A, Osborn M, Nicholas N. J Clin Pathol. 2015;68(8):601-4. PMID: 26076965. Turnbull A, Osborn M, Nicholas N. J Clin Pathol. 2015;68(8):601-4. PMID: 26076965.
12.
go back to reference Thoma A, Farrokhyar F, McKnight L, Bhandari M. Practical tips for surgical research: how to optimize patient recruitment. Can J Surg. 2010;53(3):205–10.PubMedPubMedCentral Thoma A, Farrokhyar F, McKnight L, Bhandari M. Practical tips for surgical research: how to optimize patient recruitment. Can J Surg. 2010;53(3):205–10.PubMedPubMedCentral
13.
go back to reference Donovan J, Parmasivan S, de Salis I, Torrien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014;15(1):5.CrossRefPubMedPubMedCentral Donovan J, Parmasivan S, de Salis I, Torrien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014;15(1):5.CrossRefPubMedPubMedCentral
14.
go back to reference Hamilton M, Genge A, Johnston M, Lam D, Mobach T, Marriott J, et al. Patient recruitment by neurological registries. Can J Neurol Sci. 2013;40(Suppl 2):23–6.CrossRef Hamilton M, Genge A, Johnston M, Lam D, Mobach T, Marriott J, et al. Patient recruitment by neurological registries. Can J Neurol Sci. 2013;40(Suppl 2):23–6.CrossRef
15.
go back to reference Rendell JM, Merritt RD, Geddes JR. Incentives and disincentives to participation by clinicians in randomised controlled trials. Cochrane Database Syst Rev. 2007;2:MR000021. Rendell JM, Merritt RD, Geddes JR. Incentives and disincentives to participation by clinicians in randomised controlled trials. Cochrane Database Syst Rev. 2007;2:MR000021.
16.
go back to reference Bongianni M, Orru C, Groveman BR, et al. Diagnosis of human prion Disease using Real-Time Quaking-Induced Conversion Testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017;74(2):155–62.CrossRefPubMed Bongianni M, Orru C, Groveman BR, et al. Diagnosis of human prion Disease using Real-Time Quaking-Induced Conversion Testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol. 2017;74(2):155–62.CrossRefPubMed
17.
go back to reference Bougard D, Brandel J-P, Bélondrade M, Béringue V, Segarra C, Fleury H, et al. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob Disease. Sci Transl Med. 2016;8:370ra182.CrossRefPubMed Bougard D, Brandel J-P, Bélondrade M, Béringue V, Segarra C, Fleury H, et al. Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob Disease. Sci Transl Med. 2016;8:370ra182.CrossRefPubMed
18.
go back to reference Mammana A, Baiardi S, Rossi M, Alessis F, Donaadio V, Capellari S, Caughey B, Parchi P. Detection of prions in skin punch biopsies of Creutzfeldt–Jakob Disease patients. Ann Clin Transl Neurol. 2020;7(4):559–64.CrossRefPubMedPubMedCentral Mammana A, Baiardi S, Rossi M, Alessis F, Donaadio V, Capellari S, Caughey B, Parchi P. Detection of prions in skin punch biopsies of Creutzfeldt–Jakob Disease patients. Ann Clin Transl Neurol. 2020;7(4):559–64.CrossRefPubMedPubMedCentral
19.
go back to reference Moda F et al. Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease. NEJM 2014 371(6): 530–539. Moda F et al. Prions in the Urine of Patients with Variant Creutzfeldt–Jakob Disease. NEJM 2014 371(6): 530–539.
Metadata
Title
A review of the enhanced CJD surveillance feasibility study in the elderly in Scotland, UK
Authors
Lovney Kanguru
Sarah Cudmore
Gemma Logan
Briony Waddell
Colin Smith
Anna Molesworth
Richard Knight
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2024
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04556-z

Other articles of this Issue 1/2024

BMC Geriatrics 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine